Author:
Van Deun Armand,Decroo Tom,Tahseen Sabira,Trébucq Arnaud,Schwoebel Valérie,Ortuno-Gutierrez Nimer,de Jong Bouke C.,Rieder Hans L.,Piubello Alberto,Chiang Chen-Yuan
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference46 articles.
1. World Health Organization. WHO treatment guidelines for multidrug- and rifampicin-resistant tuberculosis. 2018 update. [Pre-final text] Geneva: WHO; 2018. WHO/CDS/TB/2018.15.
2. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis;Ahmad;Lancet,2018
3. Frequently asked questions on the WHO rapid communication: key changes to the treatment of multidrug- and rifampicin-resistant TB,2018
4. World Health Organization. Active tuberculosis drug-safety monitoring and management (aDSM). Framework for implementation. WHO/HTM/TB/2015.28. Geneva: WHO; 2015.
5. Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial;Nunn;Trials,2014
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献